October - December 2010

December 28, 2010		Florida Hospital, Sanford-Burnham Medical Research Institute and Takeda Announce Partnership to Target Obesity
December 22, 2010		Takeda Completes Settlements With All Defendants in U.S. Patent Litigation Involving ACTOS® (pioglitazone HCI), ACTOplus met® (pioglitazone HCl and metformin HCl) and duetact® (pioglitazone HCl and glimepiride)
December 17, 2010		-Takeda Well-Being Program 2010 - "Giving Children in Long-term Treatment the Energy to Live"
December 8, 2010		WEEKLY VELCADE IN COMBINATION WITH RITUXIMAB IMPROVES PROGRESSION-FREE SURVIVAL AND RESPONSE RATE IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA
December 8, 2010		SUBCUTANEOUS ADMINISTRATION OF SINGLE-AGENT VELCADE DEMONSTRATES EFFICACY CONSISTENT WITH INTRAVENOUS ADMINISTRATION
December 8, 2010		Orexigen® Therapeutics' Investigational Drug Contrave® Receives Positive Recommendation from FDA Advisory Committee for Treatment of Obesity
December 8, 2010		Seattle Genetics and Millennium Report Positive Data from Phase II Trial of Brentuximab Vedotin (SGN-35) in Relapsed or Refractory ALCL at ASH Annual Meeting
December 6, 2010		Seattle Genetics and Millennium Report Positive Data from Pivotal Trial of Brentuximab Vedotin (SGN-35) in Relapsed or Refractory Hodgkin Lymphoma at ASH Annual Meeting
December 2, 2010		BAXTER AND TAKEDA COMPLETE AGREEMENT FOR VERO-CELL BASED INFLUENZA VACCINES IN JAPAN
November 29, 2010		AFFYMAX AND TAKEDA CONFIRM U.S. REGISTRATION STRATEGY FOR INVESTIGATIONAL DRUG, HEMATIDE™/PEGINESATIDE, FOLLOWING MEETING WITH FDA
November 29, 2010		Application for a Change to the Dosage and Administration of Central Precocious Puberty Medications: Leuplin® for Injection 1.88 and Leuplin® for Injection 3.75
November 11, 2010		VELCADE® (BORTEZOMIB) INDUCTION AND MAINTENANCE DATA TO BE FEATURED IN ORAL PRESENTATIONS AT AMERICAN SOCIETY OF HEMATOLOGY ANNUAL MEETING
November 11, 2010		Takeda and Sage Bionetworks Form CNS disease Research Alliance
November 4, 2010		MILLENNIUM AND TAKEDA ANNOUNCE ADVANCEMENT OF PROSTATE CANCER PROGRAM
October 29, 2010		Takeda Expands the Scope of its Corporate Venture Activities with the Formation of Takeda Ventures, Inc.
October 26, 2010		Takeda Announces Top Line Results from Phase 2 Study of Investigational Compound, TAK-442 for the patients with ACS
October 22, 2010		The London Symphony Orchestra Tours Japan under the Takeda Global Concert Series Program
October 22, 2010		Receipt of the Health, Labour and Welfare Minister's Award, the Awards for Achievement in Promoting "Reduce, Reuse, Recycle" Activities for fiscal 2010
October 20, 2010		Takeda Submits European Marketing Authorisation Application for Azilsartan Medoxomil, an Investigational Compound for the Treatment of Essential Hypertension
October 19, 2010		Takeda to Obtain Full Ownership of Tianjin Takeda Pharmaceuticals Co., Ltd. through Acquisition of Equity Held by Tianjin Lisheng Pharmaceutical
October 18, 2010		A New Phase for Takeda's Global Business Development Organization
October 13, 2010		Japan Health Sciences Foundation and Takeda Enter into License Agreement Concerning Exclusive Use of Patent Rights of Human Papillomavirus (HPV) Vaccine
October 8, 2010		Takeda and Envoy Form Schizophrenia Research Alliance
October 7, 2010		Renovation of the Takeda Garden for Medicinal Plant Conservation, Kyoto
October 1, 2010		Takeda Appoints Mr. Bruno Angelici as a New Member of "Takeda Global Advisory Board"
October 1, 2010		Takeda Announces Basic Strategies for Expansion into India